Keenova Therapeutics plc insider trading

Over the last 12 months, 2 insiders bought $220M and 0 insiders sold $0 of Keenova Therapeutics plc stock on the open market, according to SEC Form 4 filings.

Latest insider buys and sells

• Oct 14, 2026: Goldentree Asset Management Lp bought 137,000 shares ($12.3M)
• Sep 24, 2026: Goldentree Asset Management Lp bought 463,000 shares ($42.1M)
• May 20, 2026: Mule Edward A bought 397,500 shares ($36.0M)
• Apr 17, 2026: Mule Edward A bought 685,000 shares ($61.4M)
• Jan 7, 2026: Mule Edward A bought 250,000 shares ($23.1M)
• Dec 8, 2025: Mule Edward A bought 130,974 shares ($11.6M)
• Nov 19, 2025: Mule Edward A bought 68,000 shares ($6.04M)
• Nov 10, 2025: Mule Edward A bought 290,000 shares ($27.2M)
• Aug 6, 2025: Goldentree Asset Management Lp bought 36,700 shares ($3.24M)
• Aug 1, 2025: Goldentree Asset Management Lp bought 50,000 shares ($4.33M)